Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07661745

Interdisciplinary Program to Improve Quality of Life in People With Fibromyalgia

Conditions: Fibromyalgia (FM)

Sex: All
Ages: 18 Years – 85 Years
Healthy volunteers: No
Phase: NA
Enrollment: 100
Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Location: Institut Català de la Salut - Gerència Territorial Catalunya Central Manresa Barcelona

Summary

Fibromyalgia is a chronic condition characterized by widespread pain, fatigue, sleep disturbances, and psychological symptoms that significantly affect quality of life. This quasi-experimental study aims to evaluate the effectiveness of the FIBROCatCentral interdisciplinary program in improving health-related quality of life among adults with fibromyalgia receiving care in Primary Care centers in Central Catalonia, Spain. Participants in the intervention group will attend a structured multidisciplinary program consisting of 24 sessions delivered by healthcare professionals from different disciplines, including nursing, medicine, physiotherapy, nutrition, mental health, social work, and pharmacy. Outcomes will be assessed at baseline and at 3, 6, and 12 months. The primary outcome is health-related quality of life measured using the EuroQol-5D questionnaire. Secondary outcomes include fibromyalgia impact, depressive symptoms, treatment adherence, participant satisfaction, and changes in pharmacological treatment.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of fibromyalgia. * Age between 18 and 85 years. * Assigned to a participating Primary Care Center in the Central Catalonia region (Bages, Berguedà, Moianès, or Calaf areas). * Ability and willingness to provide written informed consent. Exclusion Criteria: * Severe mental illness. * Current follow-up in a specialized hospital fibromyalgia unit and previous participation in a therapeutic group program for fibromyalgia. * Inability to complete study questionnaires due to language barriers, illiteracy, or other limitations affecting reading or writing. * Refusal or inability to provide informed consent.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07661745). StuddyBuddy aggregates publicly available trial information.